Vaughan Lennox Clift
Profile
Vaughan Lennox Clift worked as a Chief Executive Officer at DetectaChem LLC from 2009 to 2009.
He also worked as a Chief Scientist-Science Payload Development at Lockheed Martin Corp.
from 1992 to 1997.
Clift served as a Vice President-Operations at Fibrocell Science, Inc. and Isolagen Technologies, Inc. He was the Chief Regulatory Affairs Officer at DMI Life Sciences, Inc. from 2009 to 2010 and at Ampio Pharmaceuticals, Inc. from 2011 to 2016.
Clift also worked as a Chief Medical & Regulatory Affairs Officer at Vyrix Pharmaceuticals, Inc. and as a Chief Scientist at Dbcd, Inc. Clift earned a doctorate degree from the University of Melbourne.
Former positions of Vaughan Lennox Clift
| Companies | Position | End |
|---|---|---|
| AMPIO PHARMACEUTICALS, INC. | General Counsel | 2016-07-01 |
DMI Life Sciences, Inc.
 DMI Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SOBR Safe, Inc., DMI Life Sciences, Inc. develops pharmaceutical products and medical devices. The private company is based in Greenwood Village, CO. DMI Life Sciences was acquired by Chay Enterprises, Inc. on March 04, 2010 for $22.60 million. The company was founded by Michael E. Macaluso. | General Counsel | 2010-02-28 |
DetectaChem LLC
 DetectaChem LLC Aerospace & DefenseElectronic Technology DetectaChem LLC is a private company that specializes in drug detection and explosive detection devices. The company is based in Houston, TX. The company's devices have been used to protect military personnel and first responders since 2005. The CEO of the company is Mark Kisner. | President | 2008-12-31 |
Isolagen Technologies, Inc.
 Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX. | Corporate Officer/Principal | 2004-12-31 |
| Dbcd, Inc. | Chief Tech/Sci/R&D Officer | 2000-12-31 |
Training of Vaughan Lennox Clift
| University of Melbourne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMPIO PHARMACEUTICALS, INC. | Health Technology |
| LOCKHEED MARTIN CORPORATION | Electronic Technology |
| AYTU BIOPHARMA, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
DetectaChem LLC
DetectaChem LLC Aerospace & DefenseElectronic Technology DetectaChem LLC is a private company that specializes in drug detection and explosive detection devices. The company is based in Houston, TX. The company's devices have been used to protect military personnel and first responders since 2005. The CEO of the company is Mark Kisner. | Electronic Technology |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX. | Commercial Services |
| Dbcd, Inc. | |
DMI Life Sciences, Inc.
DMI Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SOBR Safe, Inc., DMI Life Sciences, Inc. develops pharmaceutical products and medical devices. The private company is based in Greenwood Village, CO. DMI Life Sciences was acquired by Chay Enterprises, Inc. on March 04, 2010 for $22.60 million. The company was founded by Michael E. Macaluso. | Health Technology |
Vyrix Pharmaceuticals, Inc.
 Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | Health Technology |
- Stock Market
- Insiders
- Vaughan Lennox Clift
